Il Giornale dei Biologi - N. 2

SCIENZE
Meal and Trypsin Inhibitor Diets on Pancreatic Enzyme Secretion in
the Rat,” J. Nutr., 1957.
[13] P. McCue and K. Shetty, “Health benefits of soy isoflavonoids
and strategies for enhancement: A review,” Crit. Rev. Food Sci. Nutr.,
2004.
[14] A. Cassidy, “Physiological effects of phyto-oestrogens in relation
to cancer and other human health risks,” Proc. Nutr. Soc., 1996.
[15] J. Liggins, L. J. C. Bluck, S. Runswick, C. Atkinson, W. A. Coward,
and S. A. Bingham, “Daidzein and genistein contents of vegetables,”
Br. J. Nutr., 2000.
[16] M. Messina and M. Bennink, “Soyfoods, isoflavones and risk of
colonic cancer: A review of the in vitro and in vivo data,” Baillieres.
Clin. Endocrinol. Metab., 1998.
[17] J. Y. Dong and L. Q. Qin, “Soy isoflavones consumption and risk of
breast cancer incidence or recurrence: A meta-analysis of prospective
studies,” Breast Cancer Research and Treatment. 2011.
[18] M. M. Martínez-Montemayor, E. Otero-Franqui, J. Martinez, A.
De La Mota-Peynado, L. A. Cubano, and S. Dharmawardhane, “Individual
and combined soy isoflavones exert differential effects on
metastatic cancer progression,” Clin. Exp. Metastasis, 2010.
[19] Y. Guo, S. Wang, D. R. Hoot, and S. K. Clinton, “Suppression of
VEGF-mediated autocrine and paracrine interactions between prostate
cancer cells and vascular endothelial cells by soy isoflavones,”
J. Nutr. Biochem., 2007.
[20] A. R. Kennedy, “The Bowman-Birk inhibitor from soybeans as
an anticarcinogenic agent,” in American Journal of Clinical Nutrition,
1998.
[21] L. A. Korde et al., “Childhood soy intake and breast cancer risk in
Asian American women,” Cancer Epidemiol. Biomarkers Prev., 2009.
[22] S. A. Lee et al., “Adolescent and adult soy food intake and breast
cancer risk: Results from the Shanghai Women’s Health Study,” Am.
J. Clin. Nutr., 2009.
[23] M. Messina, “Soyfoods and soybean phyto-oestrogens (isoflavones)
as possible alternatives to hormone replacement therapy
(HRT),” European Journal of Cancer. 2000.
[24] S. Levis and M. L. Griebeler, “The Role of Soy Foods in the Treatment
of Menopausal Symptoms,” J. Nutr., 2010.
[25] J. Mardon et al., “Influence of lifelong soy isoflavones consumption
on bone mass in the rat,” Exp. Biol. Med., 2008.
[26] R. Uchida et al., “Combined effects of soy isoflavone and fish oil
on ovariectomy-induced bone loss in mice,” J. Bone Miner. Metab.,
2011.
[27] J. Wu et al., “Combined intervention of soy isoflavone and moderate
exercise prevents body fat elevation and bone loss in ovariectomized
mice,” Metabolism., 2004.
[28] H. Claassen, V. Briese, F. Manapov, B. Nebe, M. Schünke, and B.
Kurz, “The phytoestrogens daidzein and genistein enhance the insulin-stimulated
sulfate uptake in articular chondrocytes,” Cell Tissue
Res., 2008.
[29] S. Hooshmand, D. Y. Soung, E. A. Lucas, S. V. Madihally, C. W.
Levenson, and B. H. Arjmandi, “Genistein reduces the production of
proinflammatory molecules in human chondrocytes,” J. Nutr. Biochem.,
2007.
[30] C. Radzikowski, J. Wietrzyk, G. Grynkiewicz, and A. Opolski, “Genistein:
a soy isoflavone revealing a pleiotropic mechanism of action
- clinical implications in the treatment and prevention of cancer,” Postpy
higieny i medycyny doświadczalnej (Online). 2004.
[31] S. Nagarajan, “Mechanisms of anti-atherosclerotic functions of
soy-based diets,” Journal of Nutritional Biochemistry. 2010.
[32] F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton,
and M. Winston, “Soy protein, isoflavones, and cardiovascular health:
An American Heart Association Science Advisory for professionals
from the Nutrition Committee,” Circulation. 2006.
[33] A. Ørgaard and L. Jensen, “The effects of soy isoflavones on obesity,”
Experimental Biology and Medicine. 2008.
[34] C. R. Cederroth, J. Auger, C. Zimmermann, F. Eustache, and S.
Nef, “Soy, phyto-oestrogens and male reproductive function: A review,”
in International Journal of Andrology, 2010.
[35] S. Yellayi et al., “The phytoestrogen genistein induces thymic and
immune changes: A human health concern?,” Proc. Natl. Acad. Sci.
U. S. A., 2002.
[36] D. Y. Kwon, J. W. Daily, H. J. Kim, and S. Park, “Antidiabetic effects
of fermented soybean products on type 2 diabetes,” Nutrition
Research. 2010.
[37] Z. M. Liu, Y. M. Chen, S. C. Ho, Y. P. Ho, and J. Woo, “Effects
of soy protein and isoflavones on glycemic control and insulin sensitivity:
A 6-mo double-blind, randomized, placebo-controlled trial in
postmenopausal Chinese women with prediabetes or untreated early
diabetes,” Am. J. Clin. Nutr., 2010.
[38] C. K. Sites, B. C. Cooper, M. J. Toth, A. Gastaldelli, A. Arabshahi,
and S. Barnes, “Effect of a daily supplement of soy protein on
body composition and insulin secretion in postmenopausal women,”
Fertil. Steril., 2007.
[39] S. Gonźalez, V. Jayagopal, E. S. Kilpatrick, T. Chapman, and S. L.
Atkin, “Effects of isoflavone dietary supplementation on cardiovascular
risk factors in type 2 diabetes,” Diabetes Care, 2007.
[40] E. Nikander, A. Tiitinen, K. Laitinen, M. Tikkanen, and O. Ylikorkala,
“Effects of isolated isoflavonoids on lipids, lipoproteins, insulin
sensitivity, and ghrelin in postmenopausal women,” J. Clin. Endocrinol.
Metab., 2004.
[41] G. M. Dill, “Glyphosate-resistant crops: History, status and future,”
in Pest Management Science, 2005.
[42] M. Malatesta et al., “A long-term study on female mice fed on
a genetically modified soybean: Effects on liver ageing,” Histochem.
Cell Biol., 2008.
[43] S. Kimura, J. Suwa, M. Ito, and H. Sato, “Development of malignant
goiter by defatted soybean with iodine free diet in rats,” Gann,
Japanese J. Cancer Res., 1976.
[44] Y. Ishizuki, Y. Hirooka, Y. Murata, and K. Togashi, “The effects on
the thyroid gland of soybeans administered experimentally in healthy
subjects,” Nippon Naibunpi Gakkai zasshi, 1991.
[45] R. L. Divi, H. C. Chang, and D. R. Doerge, “Anti-Thyroid Isoflavones
from Soybean,” Biochem. Pharmacol., 1997.
[46] J. J. Rackis, “Biological and physiological factors in soybeans,” J.
Am. Oil Chem. Soc., 1974.
[47] R. BRESSANI and L. G. ELIAS, “Legume Foods,” in New Protein
Foods, 1974.
[48] K. D. R. Setchell, “Phytoestrogens: The biochemistry, physiology,
and implications for human health of soy isoflavones,” in American
Journal of Clinical Nutrition, 1998.
[49] D. R. Doerge and D. M. Sheehan, “Goitrogenic and estrogenic
activity of soy isoflavones,” Environ. Health Perspect., 2002.
[50] C. W. Xiao, “Health Effects of Soy Protein and Isoflavones in Humans,”
J. Nutr., 2008.
90 Il Giornale dei Biologi | Febbraio 2020